NDC codes

FDA NDC Directory
Product NDC (as listed)64380-720Labeler and product segments. Claims need a package NDC.
Product NDC at billing width64380-0720Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
64380-720-016438007200110 BLISTER PACK in 1 CARTON (64380-720-01) / 10 CAPSULE in 1 BLISTER PACKMarketed from Oct 5, 2020
64380-720-0664380072006100 CAPSULE in 1 CONTAINER (64380-720-06)Marketed from Oct 5, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Tacrolimus
Generic name (nonproprietary)
tacrolimus
Active ingredients
Tacrolimus.5 mg/1
Dosage form
Capsule
Route
Oral
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 090687
Marketing start
Listing expires
Other FDA classes
Calcineurin Inhibitors (Mechanism)
Identifiers
Product ID 64380-720_d4a7fb82-5ff6-4ffc-bec5-ff0d50347a9bSPL ID d4a7fb82-5ff6-4ffc-bec5-ff0d50347a9bSPL set ID ed7d1495-3585-409d-94f1-b3d2469d222cRxCUI 198377, 198378, 313190UNII WM0HAQ4WNMUPC 0364380721062, 0364380720065, 0364380722069
Pharmacologic class
Calcineurin Inhibitor Immunosuppressant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N464380072001 followed by a unit qualifier and the quantity

Package 64380-0720-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective . This label includes a boxed warning.

Indications (excerpt from the label)

Tacrolimus capsule is a calcineurin-inhibitor immunosuppressant indicated for the prophylaxis of organ rejection in adult patients receiving allogeneic liver, kidney, heart transplants, and pediatric patients receiving allogeneic liver transplants, in combination with other immunosuppressants. (1.1) 1.1 Prophylaxis of Organ Rejection in Kidney, Liver, or Heart Transplant Tacrolimus capsules are indicated for the prophylaxis of organ rejection, in adult patients receiving allogeneic kidney transplant [see Clinical Studies (14.1)], liver transplant [see Clinical Studies (14.2)] or heart transplant [see Clinical Studies (14.3)] and pediatric patients receiving allogeneic liver transplant [see C

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 090687

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 090687
ProductStrengthForm · routeLabelerProduct NDC
TacrolimusTacrolimus 1 mg/1CapsuleOralStrides Pharma Science Limited64380-721
TacrolimusTacrolimus 5 mg/1CapsuleOralStrides Pharma Science Limited64380-722
TacrolimusTacrolimus 1 mg/1CapsuleOralCardinal Health 107, LLC55154-4168
TacrolimusTacrolimus 1 mg/1CapsuleOralMajor Pharmaceuticals0904-7097

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in